- Price
- $207.66
- Day
- -1.60%
- Mkt Cap
- $145.98B
- 52W Range
- $160.93 – $242.80
- Volume
- 2.90M
- Beta
- 0.81
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.
Read full article
Ausdal Financial Partners Inc. purchased a new position in Danaher Corporation (NYSE: DHR) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,452 shares of the conglomerate's stock, valued at approximately $467,000. Several other institutional investors and hedge funds have also
Read full article
Bamco Inc. NY purchased a new stake in shares of Danaher Corporation (NYSE: DHR) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 315,789 shares of the conglomerate's stock, valued at approximately $227,381,000. Several other hedge funds have also bought and sold shares
Read full article
DHR's Biotechnology segment grows as China demand, bioprocessing and improving discovery markets offset regional headwinds.
Read full article
On August 19, 2026, Merck (NYSE:MRK | MRK Price Prediction) and Moderna (NASDAQ:MRNA) announced positive topline Phase 3 results from INTerpath-001 for intismeran autogene, an individualized neoantigen therapy paired with Keytruda in resected melanoma.
Read full article
Ally Financial Inc. purchased a new position in Danaher Corporation (NYSE: DHR) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 47,000 shares of the conglomerate's stock, valued at approximately $8,953,000. Danaher accounts for about 1.2% of Ally Financial Inc.'s
Read full article
Callan Family Office LLC purchased a new position in Danaher Corporation (NYSE: DHR) during the undefined quarter, according to its most recent disclosure with the SEC. The fund purchased 4,198 shares of the conglomerate's stock, valued at approximately $3,023,000. A number of other large investors also recently modified their holdings of DHR. Keating
Read full article
Allworth Financial LP acquired a new stake in shares of Danaher Corporation (NYSE: DHR) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 79,186 shares of the conglomerate's stock, valued at approximately $57,017,000. Several other hedge funds
Read full article
Advisors Capital Management LLC purchased a new position in shares of Danaher Corporation (NYSE: DHR) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,606 shares of the conglomerate's stock, valued at approximately $1,877,000. Several other large investors have also
Read full article
Allworth Financial LP acquired a new stake in Danaher Corporation (NYSE: DHR) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 11,176 shares of the conglomerate's stock, valued at approximately $2,129,000. Other hedge funds and other institutional investors also recently added to or
Read full article
Advisors Capital Management LLC acquired a new stake in shares of Danaher Corporation (NYSE: DHR) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 56,533 shares of the conglomerate's stock, valued at approximately $10,768,000. Several other large investors have also recently modified
Read full article
Bank of New York Mellon Corp acquired a new stake in shares of Danaher Corporation (NYSE: DHR) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,742,518 shares of the conglomerate's stock, valued at approximately $712,875,000. Bank of New
Read full article